Status:
UNKNOWN
Fragility Fracture Integrated Rehabilitation Management (FIRM)
Lead Sponsor:
Seoul National University Bundang Hospital
Collaborating Sponsors:
Korea Health Industry Development Institute
Conditions:
Hip Fractures
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
A number of studies for clinical pathway (CP) after hip fracture have been suggested to improve post-fracture outcome. However, CP is not carried out properly in most countries due to inadequate syste...
Detailed Description
The purpose of this prospective study To develop a standardized fragility fracture integrated rehabilitation management (FIRM) based on the critical rehabilitation pathway for fragility fractures. 1...
Eligibility Criteria
Inclusion
- Type of fracture : Femoral neck, intertrochanteric, subtrochanteric fracture
- Type of surgery : Bipolar hemiarthroplasty, THA, ORIF
Exclusion
- Surgery not for hip fracture, but for infection, arthritis, implant loosening, AVN
- Femur Shaft fracture, acetabular fracture, periprosthetic fracture, pathologic fracture for tumor
- Combined multiple fracture (ex. Upper extremity)
- Revision operation
- Disagree to participation for clinical trial
- Severe cognitive dysfunction (Obey command ≤1)
Key Trial Info
Start Date :
February 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2021
Estimated Enrollment :
288 Patients enrolled
Trial Details
Trial ID
NCT03430193
Start Date
February 12 2018
End Date
September 30 2021
Last Update
January 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 463-707